Matches in DBpedia 2015-10 for { ?s ?p "CVac, short for ‘Cancer Vaccine’, is a prospective therapeutic cancer vaccine that was originally developed in Australia. CVac works by attaching an adjuvant, mannan, to the tumor cell surface protein MUC1, a glycoprotein commonly expressed on a variety of cancers. CVac is often compared to the cancer vaccine Provenge, which gained FDA approval in 2010.CVac was developed by the biotechnology company Prima BioMed (Nasdaq: PBMD) through to Phase II clinical studies between 2001 and 2015."@en }
Showing triples 1 to 1 of
1
with 100 triples per page.
- CVac comment "CVac, short for ‘Cancer Vaccine’, is a prospective therapeutic cancer vaccine that was originally developed in Australia. CVac works by attaching an adjuvant, mannan, to the tumor cell surface protein MUC1, a glycoprotein commonly expressed on a variety of cancers. CVac is often compared to the cancer vaccine Provenge, which gained FDA approval in 2010.CVac was developed by the biotechnology company Prima BioMed (Nasdaq: PBMD) through to Phase II clinical studies between 2001 and 2015.".